FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development
This week’s Phispers brings you news on how artificial intelligence (AI) is taking centerstage in the world of pharmaceut...
Impressions : 2328
Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines
The New Year began with two mid-size deals centered around the use
of artificial intelligence (AI) in drug development. Sanofi...
Impressions : 1509
IRA price talks conclude, three meds dominate savings; Gilead’s Livdelzi from CymaBay buyout gets FDA okay
This week, the Biden-Harris Administration said it has concluded price negotiations for 10 drugs under the Inflation Reduction ...
Impressions : 1122
FDA to consider psychedelic-assisted drug for treating PTSD; Novartis buys Mariana Oncology for up to US$ 1.75 bn
Last year, the US Food and Drug Administration (FDA) had published a new draft guidance for researchers investigating the use o...
Impressions : 1155
US panel accuses China of subsidizing fentanyl production; Nigeria introduces 5-in-1 meningitis vaccine
This week’s news brings a mix of promising advancements and concerning issues. A majority of opioid overdose deaths...
Impressions : 1739
Insys founder Kapoor convicted in opioid scandal; FDA rules changing due to new technologies
This week, Phispers brings you news about John Kapoor, the founder of Insys who was found guilty of engaging in a bribery schem...
Impressions : 3737
Top drugs and pharmaceutical companies of 2018 by revenues
The drug pricing debate continued to dominate news headlines in 2018, and many companies were in the news for lowering drug pri...
Impressions : 35111
FDA approves first flu drug in 20 years; Trump proposes global index to check drug price rise
This week, Phispers brings you news on US President Donald Trump’s new payment model, proposed ahead of the midterm polls...
Impressions : 6510
High-level exit at Dr. Reddy’s; Drug stockpiling starts as firms face ‘no-deal Brexit’ blues
With Britain preparing for a ‘no-deal Brexit’, Phispers this week looks at how pharmaceutical companies are ex...
Impressions : 3396
Novartis buys gene therapy for US$ 8.7 billion; France to target healthcare for its AI strategy
This week in
Phispers, we have some good and bad news on Swiss drugmaker, Novartis. While it acquired gene-therapy company AveX...
Impressions : 4381
Apotex’s founder was murdered, its president resigns; Daiichi to recover $551 million from Ranbaxy promoters
This week in Phispers, we bring you news on the Singh brothers, the former promoters of Ranbaxy, who lost a case in the Delhi h...
Impressions : 5906
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.